Fuse Medical, Inc., (OTCPK: FZMD), a distributor and an emerging manufacturer of medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the first quarter ended March 31, 2019, with the United States Securities and Exchange Commission, on Tuesday May 7, 2019.
Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased to announce improvements in our first quarter of 2019 results, with an eleven (11) percentage point increase to
gross profit and one (1) percentage point improvement in earnings, as a percentage of net revenues, compared to the same period one year ago. We believe our 2018 investment in product development has been instrumental to our integrated distribution and manufacturing business model. Our focus first quarter was to expand product development in our spine and orthopedic implant offerings, for which we expect to see continued growth and acceptance throughout the second quarter with significant ramp-up in the last half of 2019.”
The filing can be found on the Company’s website at https://fusemedical.com/investors.